DCF — ST. JOSEPHS UNIVERSITY MEDICAL CENT
Enterprise Value: $-1.8B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.8B
Enterprise Value
$-553.5M
PV of Cash Flows
$-1.2B
PV of Terminal Value
$-2.0B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $825.7M | $-116.2M | -14.0% | $-151.1M | $-137.4M |
| Year 2 | $850.5M | $-111.2M | -13.0% | $-147.2M | $-121.6M |
| Year 3 | $876.0M | $-105.8M | -12.0% | $-142.8M | $-107.3M |
| Year 4 | $902.3M | $-104.4M | -12.0% | $-142.6M | $-97.4M |
| Year 5 | $929.3M | $-105.2M | -11.0% | $-144.6M | $-89.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.8B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$801.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14572191754236224
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5